Loading
A phase 2 trial of ES014 in desmoid tumour, run by Elpiscience (Suzhou) Biopharma, Ltd., now recruiting.
A Study in Adults With Desmoid Tumors is a phase 2 interventional study registered as NCT07541430 by Elpiscience (Suzhou) Biopharma, Ltd., with 50 participants planned, started 2026-04-30 and due to reach its primary completion in 2028-01. Interventions recorded: ES014.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Desmoid tumour and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/